A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's Disease

NCT04228666 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Due to COVID 19 Pandemic

Conditions

Alzheimer Disease

Interventions

BIOLOGICAL: HB-adMSCs

Sponsor

Hope Biosciences LLC

Collaborators

[object Object]